FDA New, GMP Do
Clinical Phase II, III Intermediates
GMP Custom synthesis, Full Document
R&D Center: 8000 sq, More than 100 hoods
Pilot Plant: 20000sq, 40 reactors from 5-200L
Manufacturing Site: 800000sq, 40 reactors from 100-5000L
Web: www.eosmedchem.com
This is my R&D youtube: https://youtu.be/r5cJdXKNXHk
| FK-3311, 116686-15-8, FK-3311 Intermediate 6953-83-9, stock 105.5g, white powder, assay by HPLC 99.9%, HNMR, LCMS we supply. |
| FK-3311, 116686-15-8, FK-3311 Intermediate 116686-84-1, stock 119.2g, white powder, assay by HPLC 99.6%, HNMR, LCMS we supply. |
| FK-3311, 116686-15-8, FK-3311 Intermediate 367-27-1, stock 315g, white powder, assay by HPLC 98.9%, HNMR, LCMS we supply. |
| FK-3311, 116686-15-8, FK-3311 Intermediate 116686-85-2, stock 147.4g, white powder, assay by HPLC 98.9%, HNMR, LCMS we supply. |
| FK-3311, 116686-15-8, FK-3311 Intermediate 116686-86-3, stock 841.7g, white powder, assay by HPLC 98.7%, HNMR, LCMS we supply. |
| FK-3311, 116686-15-8, FK-3311 Intermediate 99-92-3, stock 497.8g, white powder, assay by HPLC 99.6%, HNMR, LCMS we supply. |
| FK-3311, 116686-15-8, FK-3311 Intermediate 5317-89-5, stock 226.7g, white powder, assay by HPLC 99.5%, HNMR, LCMS we supply. |
| FK-3311, 116686-15-8, FK-3311 Intermediate 141852-51-9, stock 245.6g, white powder, assay by HPLC 99.6%, HNMR, LCMS we supply. |
| FK-3311, 116686-15-8, FK-3311 Intermediate 367-27-1, stock 807.8g, white powder, assay by HPLC 99.7%, HNMR, LCMS we supply. |
